Investor relations

Carasent is a consortium of fast-growing product companies offering mission-critial solutions like Electronic Health Records (EHR), Medical Clinic Management Software, patient engagement solutions, and business intelligence tools across various health and care sectors. In a world where efficiency and sustainability are paramount, Carasent ASA is at the forefront of providing solutions that alleviate the burden on the health and care systems.

Key figures in 2022

0 M
NOK in Revenue
0 %
Adj. ebitda Margin
0 %
Organic growth
0 M
NOK ARR Dec 2022
0 M
NOK Cash Balance

Interim report Q3, 2023

Annual report 2022

Capital Markets Day 2023

On November 7th 2023, Carasent hosted a Capital Markets Day at Carnegie head office in Stockholm. If you missed the event, you can view the recorded webcast and the presentation here:

Financial calendar

Quarterly report Q4 2023

Presentation of earnings Q4

Extraordinary General Meeting, 14 November 2023

Register by clicking on the link above

Quarterly report Q3 2023

Presentation of Q3 earnings

Half yearly-report 2023

Presentation of half-yearly report

Stock exchange releases

Annual and quarterly reports

Other reports and documents

Carasent Transparency Act Report 2023

Calling Notice – Annual Shareholder Meeting, 3 May 2023

Senior Management Remuneration Report 2022

Mandate for the nomination committee

Subscribe to our pressreleases

Are you curious to hear more?